Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Baird Medical Investment Holdings (BDMD) Accounts Payables (2023 - 2025)

Baird Medical Investment Holdings has reported Accounts Payables over the past 3 years, most recently at $1.8 million for Q4 2025.

  • For Q4 2025, Accounts Payables rose 44.1% year-over-year to $1.8 million; the TTM value through Dec 2025 reached $1.8 million, up 44.1%, while the annual FY2025 figure was $1.8 million, 44.1% up from the prior year.
  • Accounts Payables for Q4 2025 was $1.8 million at Baird Medical Investment Holdings, up from $1.3 million in the prior quarter.
  • Over five years, Accounts Payables peaked at $1.8 million in Q4 2025 and troughed at $550188.0 in Q4 2023.
  • A 3-year average of $1.2 million and a median of $1.3 million in 2024 define the central range for Accounts Payables.
  • Biggest five-year swings in Accounts Payables: surged 127.68% in 2024 and later skyrocketed 44.1% in 2025.
  • Year by year, Accounts Payables stood at $550188.0 in 2023, then surged by 127.68% to $1.3 million in 2024, then soared by 44.1% to $1.8 million in 2025.
  • Business Quant data shows Accounts Payables for BDMD at $1.8 million in Q4 2025, $1.3 million in Q4 2024, and $550188.0 in Q4 2023.